By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Celsion Corporation 

997 Lenox Drive
Suite 100
Lawrenceville  New Jersey  08648  U.S.A.
Phone: 609-896-9100 Fax: 609-896-2200


Medical Device

Company News
Celsion (CLSN) Announces Presentation Of OVATION Study Clinical Trial Design At Upcoming ASCO 2016 Meeting 5/24/2016 8:00:25 AM
Celsion (CLSN) Reports First Quarter 2016 Financial Results And Provides Business Update 5/16/2016 7:44:48 AM
Celsion (CLSN) To Hold First Quarter 2016 Financial Results Conference Call On Monday, May 16, 2016 5/9/2016 7:31:25 AM
Celsion (CLSN) Announces Positive Data From The First Cohort Of Patients In The OVATION Study 5/2/2016 6:16:26 AM
Celsion (CLSN) Announces Enrollment Of First Patient In The OPTIMA Study In China 4/26/2016 6:47:06 AM
Celsion (CLSN) Presents Compelling Data At AACR 2016 Demonstrating Synergistic Anti-Cancer Effect Of GEN-1 IL-12 Immunotherapy Plus Avastin And Doxil 4/19/2016 6:39:08 AM
Celsion (CLSN) Announces Upcoming Presentation At AACR 2016 Highlighting Potential Of GEN-1 IL-12 Immunotherapy In Ovarian Cancer 4/12/2016 7:31:07 AM
Celsion (CLSN) Reports Year End 2015 Financial Results And Provides Business Update 3/30/2016 6:49:11 AM
Celsion (CLSN) To Hold Year-End 2015 Financial Results Conference Call On Wednesday, March 30, 2016 3/23/2016 7:52:18 AM
Celsion (CLSN) Announces Presentation Of Preclinical Data For GEN-1 IL-12 Immunotherapy In Combination With Avastin And Doxil At The AACR Annual Meeting 2016 3/17/2016 6:37:08 AM